Skip to main content

GW HENSSLER & ASSOCIATES LTD

Position in NVO — Novo Nordisk A S

CIK 1080369 KENNESAW, GA

Position in NVO

as of Jun 30, 2026 · filed Jul 28, 2026
Position Value
$357,153
+$83,366 QoQ
Shares Held
7,450
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#830
of 1,348 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GW HENSSLER & ASSOCIATES LTD holds $66,383,683 across 9 Drug Manufacturers - General names. NVO ranks #7 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
7,450 $357,153

All Filings in NVO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $357,153 7,450
2026-03-31 $273,787 7,450
2025-12-31 $404,953 7,959
2025-09-30 $441,644 7,959
2025-06-30 $549,330 7,959
2025-03-31 $552,672 7,959
2024-12-31 $727,643 8,459
2024-09-30 $1,007,213 8,459
2024-06-30 $1,207,437 8,459
2024-03-31 $1,086,135 8,459
2023-12-31 $875,083 8,459
2023-09-30 $828,827 9,114
2023-06-30 $737,459 4,557
2023-03-31 $725,200 4,557
2022-12-31 $616,744 4,557
2022-09-30 $479,220 4,810
2022-06-30 $566,621 5,085
2022-03-31 $572,018 5,151
2021-12-31 $760,144 6,787
2021-06-30 $653,657 7,803
2021-03-31 $620,735 9,207
2020-12-31 $14,095,101 201,791
2020-09-30 $13,946,820 200,876
2020-06-30 $25,797,155 393,970
2020-03-31 $22,495,837 373,685